Category: Prescription Drugs

Highlights from The Workers Compensation Research Institute 2019 Annual Issues and Research Conference

February 28-March 1, 2019, marked the 35th annual Workers Compensation Research Institute (WCRI) Issues and Research Conference. The theme of this year’s event, “Breaking Down Barriers to Improve Injured Workers’ Outcomes,” signified two core ideas that were evident in each session. The first was that workers compensation can no longer operate in a silo. As ...

2019 Brings Progress on Prescription Drug Cost Control Efforts at State and Federal Level

As states and the federal government grapple with how best to address the issue of rising prescription drug costs, various models have emerged at the federal level that are similar to efforts underway at the State level. The Administration has called upon states to create innovative approaches to state Medicaid programs, particularly by examining value-based ...

1115 Waiver Decisions issued by CMS

As we addressed in our report this past Spring, the use of Section 1115 Medicaid Waivers to address rising drug costs was a notable feature of the Federal administration’s recent drug proposal, and is an emerging policy trend.[1] The Federal administration’s 2019 budget proposes providing five states with Medicaid demonstration authority to test “drug coverage ...

Health Policy News October Edition

 Introduction This month’s edition of Health Policy News focuses on recent developments relative to drug policy, which has been an ever-growing focus at the State and Federal level. We continue our coverage of efforts relative to drug cost control with short summaries of recent decisions on Section 1115 Waivers submitted by Massachusetts and Oklahoma, and ...

Health Policy News May 2018

In this edition of Health Policy News, we continue our series of updates on state innovation in health policy. In follow-up to last year’s series on 1332 State Innovation Waivers, this year we have focused on other ideas and efforts percolating across the country and aimed at strengthening health insurance markets and expanding access to ...

Health Policy News March 2018

This month’s edition focuses on efforts underway across the country to protect consumers from rising prescription drug costs and reduce or cap state drug spending. Health Policy News subject matter experts released a special report and legislative tracking tool outlining state and federal efforts, along with suggestions for states on how to approach this high ...

Tackling Rising Prescription Drug Costs – a report on state and federal efforts

On March 29th, subject matter experts from Health Policy News held a webinar and Q&A to discuss efforts at the state and federal level to address the rising cost of prescription drugs.  Many states are in the midst of their legislative cycles, with the issue of rising pharmaceutical costs on agendas across the country. Topics ...

Health Policy News November 2017

Along with the changing weather, this time of year brings some typical health policy events, which are the focus of this month’s edition of Health Policy News. We start with our in-depth analysis of the Proposed Notice of Benefit and Payment Parameters (NBPP) for 2019, which the Centers for Medicare & Medicaid Services (CMS) released ...

White House releases report on opioid crisis

On November 1, 2017, the White House released a report drafted by the President’s Commission on Combatting Drug Addiction and the Opioid Crisis.  The report offers 56 recommendations for action by Congress, federal agencies, state governments, health care provider organizations, and health care payers. Those include: New training programs on screening patients for substance use ...